Figure 4.
Inflammasomes mRNA expression of cells treated with different concentrations of LPS for 24 h. (A) NLRP3, (B) ASC, (C) Caspase-1, (D) Caspase-4, and (E) GSDMD. Each treatment had three samples (n = 3) and was repeated three times to reduce system errors; “※” means there was a significant difference (P < 0.05) compared with negative control (LPS, 0 µg/ml).